Therapeutic use of stem cells obtained from the cord umbilical in patients with diabetes mellitus type I
DOI:
https://doi.org/10.56294/shp2024119Keywords:
cells, disease, diabetes, therapy, umbilical cordAbstract
Current medicine with a boom in stem cell therapies has great enthusiasm and hope to advance in the cure of some diseases that for many years have affected a large part of the world's population and that as the years go by, the incidence, relapses increase. of the disease, crisis, hospitalizations, comorbidities, complications that can not only affect the patient's health more, but also increase costs for hospitals and the state, in the midst of saving the lives of these patients; For years, the pharmaceutical industry has also produced different medications in search of a less invasive and more specific treatment for each patient, also increasing the cost of maintaining this disease; said disease diabetes mellitus (DM). Diabetes mellitus is a metabolic disease characterized by hyperglycemia and β-cell dysfunction. In this research we have the objective of focusing the therapeutics and efficacy on stem cells derived from the umbilical cord. that specifically provide several advantages and unique characteristics for said disease.
References
1. Argentina.gob.ar. Diabetes Mellitus [Internet]. 2017 ago 9 [citado 2025 abr 4]. Disponible en: https://www.argentina.gob.ar/salud/glosario/diabetes
2. Armson BA, Allan DS, Casper RF. Umbilical cord blood: counselling, collection, and banking. J Obstet Gynaecol Can. 2015 Sep;37(9):832-44. doi:10.1016/S1701-2163(15)30157-2
3. Bieback K, Kern S, Klüter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625-34. doi:10.1634/stemcells.22-4-625
4. Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood. 2015 Apr 23;125(17):2605-13. doi:10.1182/blood-2014-12-570200
5. El-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudis. East Mediterr Health J. 2000;6(2-3):276-82.
6. Ishii T, Eto K. Fetal stem cell transplantation: past, present, and future. World J Stem Cells. 2014 Sep 26;6(4):404-20. doi:10.4252/wjsc.v6.i4.404
7. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, et al. Isolation and characterization of Human Umbilical Cord Mesenchymal Stem Cells with Hematopoiesis-Supportive Function and Other Potentials». Haematologica 91, n.o 8 (agosto de 2006): 1017-26.
8. Nicolau F, Quetglas M, Ramis JM, Monjo M, Arbós A, Gayà A, Calvo J, Muncunill J. Obtención de células madre mesenquimales a partir de cordones umbilicales procedentes de un programa altruista de donación de sangre de cordón. Inmunología (1987). 2013;:3-11.
9. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330-7. doi:10.1634/stemcells.2004-0013.
Published
Issue
Section
License
Copyright (c) 2024 Daniela Villada Escobar, Karina Bustamante Galarza (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
